Literature DB >> 28559271

Prevalence of Invasive Infections Due to Carbapenem-Resistant Enterobacteriaceae among Adult Patients in U.S. Hospitals.

Thomas Lodise1, Michael J Ye2, Qi Zhao2.   

Abstract

This large-scale retrospective analysis (n = 60,551) of the Premier inpatient database (1 January 2011 to 31 December 2014) found an overall prevalence of carbapenem-resistant Enterobacteriaceae strains of 2.3% (range, 0.9% to 5.8% by geographic region) among patients with infections due to Enterobacteriaceae Ongoing monitoring and development of decision support tools/algorithms are needed for identification of high-risk patients.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  anti-infective agents; bacteremia; bacterial drug resistance; bacterial infections; bacterial pneumonia; carbapenems; intra-abdominal infections; urinary tract infections

Mesh：

Substances：

Year:  2017        PMID： 28559271      PMCID： PMC5527580          DOI： 10.1128/AAC.00228-17

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  1 in total

Review 1.  International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases.

Authors:  Kalpana Gupta; Thomas M Hooton; Kurt G Naber; Björn Wullt; Richard Colgan; Loren G Miller; Gregory J Moran; Lindsay E Nicolle; Raul Raz; Anthony J Schaeffer; David E Soper
Journal:  Clin Infect Dis       Date:  2011-03-01       Impact factor: 9.079
  1 in total
  8 in total

1.  The 30-Day Economic Burden of Newly Diagnosed Complicated Urinary Tract Infections in Medicare Fee-for-Service Patients Who Resided in the Community.

Authors:  Thomas P Lodise; Michael Nowak; Mauricio Rodriguez
Journal:  Antibiotics (Basel)       Date:  2022-04-26

2.  Characteristics of Carbapenem-Resistant Enterobacteriaceae in Ready-to-Eat Vegetables in China.

Authors:  Bao-Tao Liu; Xiao-Yan Zhang; Shu-Wei Wan; Jun-Jie Hao; Rui-De Jiang; Feng-Jing Song
Journal:  Front Microbiol       Date:  2018-06-01       Impact factor: 5.640

3.  Retrospective Cohort Study of the 12-Month Epidemiology, Treatment Patterns, Outcomes, and Health Care Costs Among Adult Patients With Complicated Urinary Tract Infections.

Authors:  Thomas P Lodise; Janna Manjelievskaia; Elizabeth Hoit Marchlewicz; Mauricio Rodriguez
Journal:  Open Forum Infect Dis       Date:  2022-06-20       Impact factor: 4.423

4.  Epidemiology of Complicated Urinary Tract Infections due to Enterobacterales Among Adult Patients Presenting in Emergency Departments Across the United States.

Authors:  Thomas P Lodise; Teena Chopra; Brian H Nathanson; Katherine Sulham; Mauricio Rodriguez
Journal:  Open Forum Infect Dis       Date:  2022-06-24       Impact factor: 4.423

5.  Epidemiology of Antimicrobial Resistance Among Blood and Respiratory Specimens in the United States Using Genotypic Analysis From a Cloud-Based Population Surveillance Network.

Authors:  Tristan T Timbrook; Katherine E Olin; Usha Spaulding; Ben W Galvin; Charles B Cox
Journal:  Open Forum Infect Dis       Date:  2022-06-17       Impact factor: 4.423

6.  Burden of illness in US hospitals due to carbapenem-resistant Gram-negative urinary tract infections in patients with or without bacteraemia.

Authors:  Ryan K Shields; Yun Zhou; Hemanth Kanakamedala; Bin Cai
Journal:  BMC Infect Dis       Date:  2021-06-14       Impact factor: 3.090

7.  Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study.

Authors:  Eilish McCann; Arjun Srinivasan; C Andrew DeRyke; Gang Ye; Daryl D DePestel; John Murray; Vikas Gupta
Journal:  Open Forum Infect Dis       Date:  2018-09-21       Impact factor: 3.835

8.  Intravenous Colistin Monotherapy versus Combination Therapy against Carbapenem-Resistant Gram-Negative Bacteria Infections: Meta-Analysis of Randomized Controlled Trials.

Authors:  I-Ling Cheng; Yu-Hung Chen; Chih-Cheng Lai; Hung-Jen Tang
Journal:  J Clin Med       Date:  2018-08-10       Impact factor: 4.241
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.